Developing drugs is becoming more difficult and costly, despite tech advancements. Not only does it take up to a decade and ~$2.7B to develop a new drug but by 2030, patents will expire for nearly 200 drugs. To remedy time and cost losses, techbio startups are working to make every drug development phases faster, cheap